BAZEDOXIFENE ACETATE
|
|
|
- CAS-Nr.
- 198481-33-3
- Englisch Name:
- BAZEDOXIFENE ACETATE
- Synonyma:
- Viviant;Way-140424;WAY-TES 424;WAY-TSE-424;Unii-J70472ud3d;3-Oxo Ziprasidone;Bazedoxifene acetat;BAZEDOXIFENE ACETATE;Bazedoxifene (acetate)-B;Bazedoxifene acetate [usan]
- CBNumber:
- CB71011079
- Summenformel:
- C32H38N2O5
- Molgewicht:
- 530.67
- MOL-Datei:
- 198481-33-3.mol
|
BAZEDOXIFENE ACETATE Eigenschaften
- Schmelzpunkt:
- 174-178°
- storage temp.
- -20°C
- Löslichkeit
- DMSO: soluble15mg/mL, clear
- Aggregatzustand
- powder
- Farbe
- white to beige
- InChIKey
- DGEPGJZKMFNSDD-UHFFFAOYSA-N
- SMILES
- C(=O)(O)C.C(C1C=CC(OCCN2CCCCCC2)=CC=1)N1C2C=CC(O)=CC=2C(C)=C1C1C=CC(O)=CC=1
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen. |
|
BAZEDOXIFENE ACETATE Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale Beige Solid
Verwenden
Bazedoxifene Acetate is a nonsteroidal selective estrogen receptor modulator (SERM). Bazedoxifene Acetate is used as an antiosteoporotic.
Clinical Use
The selective estrogen receptor modulator bazedoxifene acetate was approved in Spain for the treatment
of osteoporosis in postmenopausal women. The drug was discovered by Wyeth (now Pfizer) and
licensed to Almirall. Clinical trials with bazedoxifene along with conjugated estrogens
demonstrated significant improvement in bone mineral density and prevented bone loss in
postmenopausal women without osteoporosis. It also reduces fracture risks among women with
postmenopausal osteroporosis.
BAZEDOXIFENE ACETATE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
BAZEDOXIFENE ACETATE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 212)Lieferanten
198481-33-3()Verwandte Suche:
- BAZEDOXIFENE ACETATE
- 1-(p-(2-(Hexahydro-1H-azepin-1-yl)ethoxy)benzyl)-2-(p-hydroxyphenyl)-3-methylindol-5-ol monoacetate (salt)
- 1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-, monoacetate (salt)
- Bazedoxifene acetate [usan]
- Unii-J70472ud3d
- Viviant
- Way-140424
- 1-((4-(2-(Hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol monoacetate
- 1-[[4-[2-(Hexahydro-1H-azepin-1-yl)ethoxy]phenyl]Methyl]-2-(4-hydroxyphenyl)-3-Methyl-
- WAY-TES 424
- 1-[4-(2-Azepan-1-yl-ethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetate
- WAY-TSE-424
- 3-Oxo Ziprasidone
- Bazedoxifene acetat
- 1-[[4-[2-(Hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetate
- TSE 424; VIVIANT; WAY-TES 424
- 1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, acetate (1:1)
- Bazedoxifene Acetate (TSE-424)
- Bazedoxifene (acetate)-B
- Bazedoxifene acetateQ: What is
Bazedoxifene acetate Q: What is the CAS Number of
Bazedoxifene acetate Q: What is the storage condition of
Bazedoxifene acetate Q: What are the applications of
Bazedoxifene acetate
- 198481-33-3
- 1984841-33-3
- 1198481-33-3
- C30H34N2O3C2H4O2
- Bazedoxifene Acetate
- Inhibitors
- 198481-33-3
